Why Eli Lilly's Profits Aren't a Sure Thing for Marketers Despite Obesity Drug Push
Eli Lilly appears to be making as many of its popular obesity and diabetes drugs as possible, but shortages are…
health care industry
J&J, Bristol Myers Squibb Lose Challenges in Medicare Drug Price Negotiations
Jonathan Raá | Nurfoto | fake images A federal judge in New Jersey on Monday rejected Johnson and Johnson'sand Bristol-Myers…
Walmart will close health centers and virtual care service
Walmart on Tuesday said it will close all of its health care clinics nationwide, a surprising reversal of its plans…
Eli Lilly (LLY) earnings in the first quarter of 2024
The Eli Lilly logo is displayed at one of the company's offices in San Diego, California, U.S., on September 17,…
Unjustified drop after GEHC results is a buying opportunity
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
FTC Challenges Drug Makers' Patents, Including Ozempic's
A box of Ozempic and its contents on a table in Dudley, North Tyneside, Britain, on October 31, 2023. Lee…
Humira sales fall, but AbbVie has successors
Humira, the injectable treatment for rheumatoid arthritis, appears at a pharmacy in Cambridge, Massachusetts. JB Reed | Bloomberg | fake…
Eli Lilly (LLY) Says It Can Overcome the Problem of Too Much Demand for High Quality
Eli Lilly's improved guidance stole the show on Tuesday, offsetting mixed first-quarter results and sending shares up nearly 6%. The…
Pfizer (PFE) earnings in the first quarter of 2024
Jakub Porzycki | Nurfoto | fake images Pfizer on Wednesday reported first-quarter revenue and adjusted earnings that beat expectations and…
CVS Health (CVS) First Quarter 2024 Earnings
CVS Health On Wednesday it reported first-quarter revenue and adjusted earnings that missed expectations and cut its full-year profit outlook,…